Medicare Enrolled

Dr. Padmapriya Sivaraman, M.D.

Optician · North Richland Hills, TX
Practice pattern: Mixed Practice— Diverse clinical practice across multiple procedure types
Low-engagement
8221 MID CITIES BLVD., North Richland Hills, TX 76182
2145400700
In practice since 2011 (15 years)
NPI: 1699070391 verify on NPPES ↗
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating. This page presents federal public records about Dr. Sivaraman from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Sivaraman? Request a correction or review of any data shown here. Provider portal →

What this data tells you about Dr. Sivaraman

Dr. Padmapriya Sivaraman is an optician in North Richland Hills, TX, with 15 years in practice. Based on federal Medicare data, Dr. Sivaraman performed 5,413 Medicare services across 1,599 unique beneficiaries.

Between the years covered by Open Payments, Dr. Sivaraman received a total of $12,958 from 32 pharmaceutical and/or device companies across 785 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in optician. Most payments are for meals and travel — low-value interactions common across virtually all practicing physicians. Patients may wish to discuss these relationships with their provider.

The Data Coverage level for Dr. Sivaraman is Very High — reflecting how much public federal data is available about this provider. This is not a quality rating. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.

✓ 15 years in practice▲ Top 13% volume in TX$ $12,958 industry payments

Medicare Practice Summary

Medicare Utilization ↗
5,413
Medicare services
Top 13% in TX for optician
1,599
Unique beneficiaries
$21
Avg. Medicare payment
Medicare patients only (65+ / disabled) · Not a quality rating · How to read this →
~361 Medicare services per year of practice

Top procedures by volume

Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.

ProcedureVolumeAvg. paidAvg. submitted
Denosumab injection (Prolia/Xgeva)2,520$18$69
Office visit, established patient (30-39 min)364$89$377
Comprehensive metabolic blood panel363$10$32
Blood draw (venipuncture)357$8$27
Complete blood count (CBC) with differential352$7$23
C-reactive protein test (inflammation marker)345$5$16
Sed rate test (inflammation marker)344$3$8
Measurement of complement (immune system proteins), antigen,110$11$36
Administration of non-hormonal anti-neoplastic chemotherapy under skin or into muscle104$58$218
Vitamin D level test62$28$89
Measurement of antibody for assessment of autoimmune disorder, any method50$17$54
Screening test for antibody to noninfectious agent41$11$36
Hepatitis b core antibody measurement39$12$36
Hepatitis b surface antibody measurement39$10$32
Hepatitis c antibody measurement39$13$43
Detection test by immunoassay technique for hepatitis b surface antigen39$10$31
Office visit, established patient, complex (40-54 min)39$125$530
New patient office visit, complex (60-74 min)37$161$648
Measurement of antibody for rheumatoid arthritis assessment33$12$39
Rheumatoid factor level32$5$17
Screening test for autoimmune disorder27$11$36
Automated urinalysis21$2$7
Joint injection, major joint17$44$191
Uric acid level test14$4$14
Thyroid stimulating hormone (TSH) test13$15$50
Urinalysis with microscopic exam12$3$10
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.

Industry Payment Transparency

Open Payments through 2024 ↗
$12,958
Total received (2018-2024)
Avg $1,851/year across 7 years
Top 14% in TX for optician
32
Companies
785
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →

Payment profile

Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.

Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$12,864 (99.3%)
Speaking / Promotional
Speaker programs, honoraria, and industry-sponsored educational events
$94 (0.7%)

Payment trend by year

Annual totals from pharmaceutical and medical device companies.

2024
$2,825
2023
$2,316
2022
$1,239
2021
$311
2020
$618
2019
$2,905
2018
$2,745

Payments by company (2024)

Consulting
Speaking
Meals & Travel
Research
Amgen Inc.
$1,546
UCB, Inc.
$1,503
PFIZER INC.
$1,238
Janssen Biotech, Inc.
$1,067
AbbVie, Inc.
$1,065
Novartis Pharmaceuticals Corporation
$1,004
ABBVIE INC.
$861
AbbVie Inc.
$646
E.R. Squibb & Sons, L.L.C.
$618
Horizon Therapeutics plc
$545
Lilly USA, LLC
$493
GlaxoSmithKline, LLC.
$433
GENZYME CORPORATION
$389
AstraZeneca Pharmaceuticals LP
$345
Horizon Pharma plc
$191
Genentech USA, Inc.
$121
Mallinckrodt Enterprises LLC
$113
Mallinckrodt LLC
$109
ANI Pharmaceuticals, Inc.
$76
Boehringer Ingelheim Pharmaceuticals, Inc.
$71
SANOFI-AVENTIS U.S. LLC
$67
Sandoz Inc.
$66
Merck Sharp & Dohme Corporation
$58
Alexion Pharmaceuticals, Inc.
$56
MEDAC PHARMA, INC.
$56
Mallinckrodt Hospital Products Inc.
$51
Takeda Pharmaceuticals U.S.A., Inc.
$47
Aurinia Pharma U.S., Inc.
$39
Antares Pharma, Inc.
$34
Teva Pharmaceuticals USA, Inc.
$23
MEDEXUS PHARMA, INC.
$16
Flexion Therapeutics, Inc.
$11
Top 3 companies account for 33.1% of total payments
Associated products mentioned in payments ›
ACTHAR · Actemra · BENLYSTA · Bimzelx · COSENTYX · CYLTEZO · Cimzia · EVENITY · Enbrel · FORTEO · HUMIRA · HYRIMOZ · Humira · KEVZARA · KRYSTEXXA · LUPKYNIS · LYRICA · NUCALA · OCTAGAM IMMUNE GLOBULIN (HUMAN) · ORENCIA · Otezla · Otrexup · PENNSAID · PURIFIED CORTROPHIN GEL · Prolia · RAYOS · RENFLEXIS · RHEUMATOID ARTHRITIS DISEASE · RINVOQ · Rasuvo · Rinvoq · Rituxan · SAPHNELO · SIMPONI · SIMPONI ARIA · SKYRIZI · STELARA · STRENSIQ · TALTZ · TREMFYA · Truxima · Uloric · VIMOVO · XELJANZ · Zilretta
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →

Most payments (99%) are for meals and travel — low-value interactions that are common across virtually all practicing physicians.

Equivalent to $239 per 100 Medicare services performed
Looking for a optician in North Richland Hills?
Compare opticians in the North Richland Hills area by procedure volume, costs, and industry payment transparency.
Browse opticians nearby

Geographic Context

Opticians within 10 mi
314
Per 100K population
14.7
County median income
$81,905
Nearest hospital
SAINT CAMILLUS MEDICAL CENTER
2.6 mi

Data Sources

Provider Registry NPPESWeekly updates
Medicare Enrollment PECOSMonthly updates
Practice Data Medicare Util.Annual (CY lag)
Industry Payments Open PaymentsCY 2024
Disciplinary History— Not publicN/A

This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This measures how much public data is available about a provider — not how good they are. How we calculate this →

Summary

Dr. Sivaraman is a mixed practice specialist, with above-average Medicare volume (top 13% in TX), and high industry engagement (low-engagement, top 14%), with 15 years of practice experience.

This summary is auto-generated from federal data. It describes data availability and patterns — not clinical quality. Read our methodology →

Frequently Asked Questions

Is Dr. Sivaraman experienced with denosumab injection (prolia/xgeva)?
Based on Medicare claims data, Dr. Sivaraman performed 2,520 denosumab injection (prolia/xgeva) services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Sivaraman receive payments from pharmaceutical companies?
Yes. Dr. Sivaraman received a total of $12,958 from 32 companies across 785 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Sivaraman's costs compare to other opticians in North Richland Hills?
Dr. Sivaraman's average Medicare payment per service is $21. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Sivaraman) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
About this page

All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.

This page is not medical advice, an endorsement, a recommendation, or a quality rating. The Transparency Score measures data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.

Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology

Data Disclaimer — Data sourced from the Centers for Medicare & Medicaid Services (CMS): National Plan and Provider Enumeration System (NPPES), Open Payments program, Medicare Provider Utilization and Payment Data, and Provider Enrollment & Certification data (PECOS). Published under the Freedom of Information Act (FOIA). This website is not affiliated with, endorsed by, or authorized by CMS, HHS, or the U.S. Government. Data may contain errors as reported to CMS by providers and reporting entities. Payments from industry are legal and do not indicate wrongdoing. Medicare data reflects only patients aged 65+ or those with qualifying disabilities. For corrections, contact CMS directly. This information does not constitute medical advice and should not be used as the sole basis for choosing a healthcare provider. Procedure descriptions use plain language and do not reference CPT® codes, which are copyrighted by the American Medical Association. Full methodology → · Report a data error → · Privacy policy →